Back to today’s briefing

Story perspectives

Trump's Order Aims to Lower Drug Prices, Sparks Controversy

5/27/2025

42 7

Summary

Story summary

President Trump’s executive order, signed on May 12, 2025, seeks to bring U.S. drug prices in line with those of similar nations, requiring pharmaceutical companies to match brand-name medication prices. While this move could lead to substantial savings for consumers, critics fear it may hinder innovation and spark legal battles, leaving the future of drug costs in question.

1 of 1

Story summary

President Trump’s executive order, signed on May 12, 2025, seeks to bring U.S. drug prices in line with those of similar nations, requiring pharmaceutical companies to match brand-name medication prices. While this move could lead to substantial savings for consumers, critics fear it may hinder innovation and spark legal battles, leaving the future of drug costs in question.